Zurcher Kantonalbank Zurich Cantonalbank Lowers Stake in Liquidia Technologies, Inc. (NASDAQ:LQDA)

Zurcher Kantonalbank Zurich Cantonalbank reduced its position in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA) by 15.6% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,221 shares of the company’s stock after selling 3,551 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Liquidia Technologies were worth $284,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC lifted its holdings in shares of Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock worth $44,000 after buying an additional 1,173 shares in the last quarter. Cetera Investment Advisers grew its holdings in shares of Liquidia Technologies by 4.3% in the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company’s stock worth $367,000 after purchasing an additional 1,277 shares during the last quarter. Valmark Advisers Inc. grew its holdings in Liquidia Technologies by 7.4% during the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company’s stock worth $275,000 after acquiring an additional 1,283 shares in the last quarter. Bleakley Financial Group LLC grew its holdings in Liquidia Technologies by 6.4% during the 1st quarter. Bleakley Financial Group LLC now owns 25,308 shares of the company’s stock worth $373,000 after acquiring an additional 1,523 shares in the last quarter. Finally, Summit Investment Advisors Inc. lifted its position in shares of Liquidia Technologies by 35.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company’s stock valued at $78,000 after buying an additional 1,719 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on LQDA. Needham & Company LLC reissued a “buy” rating on shares of Liquidia Technologies in a research report on Monday, June 2nd. Wall Street Zen raised shares of Liquidia Technologies from a “sell” rating to a “hold” rating in a research note on Thursday, May 22nd. Bank of America decreased their price objective on Liquidia Technologies from $25.00 to $23.00 and set a “buy” rating on the stock in a report on Wednesday, June 11th. Oppenheimer set a $13.00 price target on shares of Liquidia Technologies and gave the company an “underperform” rating in a research report on Monday, May 19th. Finally, BTIG Research reissued a “buy” rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $26.89.

Liquidia Technologies Price Performance

Liquidia Technologies stock opened at $20.45 on Friday. Liquidia Technologies, Inc. has a one year low of $8.26 and a one year high of $20.64. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93. The business has a fifty day moving average of $15.59 and a two-hundred day moving average of $15.16. The company has a market cap of $1.75 billion, a P/E ratio of -12.94 and a beta of 0.14.

Liquidia Technologies (NASDAQ:LQDA) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.03). The business had revenue of $3.12 million for the quarter, compared to analysts’ expectations of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. As a group, analysts predict that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Insider Buying and Selling at Liquidia Technologies

In other Liquidia Technologies news, CEO Roger Jeffs sold 20,252 shares of Liquidia Technologies stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $14.28, for a total value of $289,198.56. Following the completion of the sale, the chief executive officer directly owned 1,038,560 shares of the company’s stock, valued at approximately $14,830,636.80. The trade was a 1.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael Kaseta sold 30,000 shares of Liquidia Technologies stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $20.00, for a total value of $600,000.00. Following the completion of the sale, the chief financial officer owned 376,412 shares of the company’s stock, valued at $7,528,240. This trade represents a 7.38% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 90,277 shares of company stock valued at $1,469,392. Corporate insiders own 26.50% of the company’s stock.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).